DOCTOREYE X-EYE is an AI software solution that analyzes optical fundus images to detect the presence of ophthalmic diseases including age-related Macular degeneration, Diabetic retinopathy, Glaucoma, and Epiretinal membrane within seconds.
It supports clinical decision-making by healthcare professionals.
*Approval from the Ministry of Food and Drug Safety (No. D 26-1)
X-BRAIN analyzes optical fundus images to identify potential brain diseases and clinically significant findings, thereby supporting clinical decision-making by healthcare professionals.
*DOCTOREYE X-BRAIN is currently under research and development.
fundus Camera + AI
AI software - DOCTOREYE series
*On device AI is currently under research and development.
Global Evidence Base
Fundus to EYE / Coronary Artery / Aneurysm
Non-mydriatic fundus imaging enables early detection of glaucoma.
Non-mydriatic fundus imaging enables early detection of glaucoma.
A single-field fundus photograph enables efficient diabetic retinopathy screening.
A single-field fundus photograph enables efficient diabetic retinopathy screening.
DOCTOREYE X-EYE is an AI software solution that analyzes optical fundus images to detect the presence of ophthalmic diseases including age-related Macular degeneration, Diabetic retinopathy, Glaucoma, and Epiretinal membrane within seconds.
It supports clinical decision-making by healthcare professionals.
*Approval from the Ministry of Food and Drug Safety (No. D 26-1)
DOCTOREYE |X-BRAIN
Our AI-based system analyzes optical fundus images to identify potential brain diseases and clinically significant findings, thereby supporting clinical decision-making by healthcare professionals.
*DOCTOREYE X-BRAIN is currently under research and development.
On device AI
fundus Camera + AI
AI software - DOCTOREYE series
*On device AI is currently under research and development.
Fundus to EYE / Coronary Artery stenosis / Aneurysm
Non-mydriatic fundus imaging enables
early detection of glaucoma
A single-field fundus photograph enables efficient diabetic retinopathy screening.
Fundus imaging detects subtle retinal
membrane changes
Predicting the Degree of Coronary Artery
Stenosis Through Retinal Vascular Characteristics
and Minimal Clinical Information
Optimizing retinal images based carotid atherosclerosis prediction with explainable foundation models
Integrating oculomics with genomics reveals imaging biomarkers for preventive and personalized prediction of arterial aneurysms
Pie healthcare : AI software
DOCTOR EYE | X-EYE
DOCTOREYE X-EYE is an AI software solution that analyzes optical fundus images to detect the presence of ophthalmic diseases including age-related Macular degeneration, Diabetic retinopathy, Glaucoma, and Epiretinal membrane within seconds.
By doing so, it supports clinical decision-making by healthcare professionals.
*Approval from the Ministry of Food and Drug Safety (No. D 26-1)
Key regions analyzed by the AI can be visualized through heat maps.
Diabetic
Diabetic
Diabetic heatmap
Diabetic heatmap
AMD
AMD
AMD heatmap
AMD heatmap
3.Report
To enable users to intuitively review examination results, the system provides the analysis results for easy interpretation.
4.R&D
2024: Development of DOCTOREYE X-EYE completed
2025: Regulatory and commercialization processes for DOCTOREYE X-EYE are currently underway
Approval from the Ministry of Food and Drug Safety (No. D 26-1)
Piehealthcare : AI software
DOCTOR EYE | X-EYE
DOCTOREYE X-EYE is an AI software solution that analyzes optical fundus images to detect the presence of ophthalmic diseases including age-related Macular degeneration, Diabetic retinopathy, Glaucoma, and Epiretinal membrane within seconds.
By doing so, it supports clinical decision-making by healthcare professionals.
*Approval from the Ministry of Food and Drug Safety (No. D 26-1)
Characteristic : X-EYE
1.EYE dieases
Macular degeneration
Diabetic retinopathy
Glaucoma
Epiretinal membrane
Macular degeneration
Macular degeneration
Diabetic retinopathy
Diabetic retinopathy
Glaucoma
Glaucoma
Epiretinal membrane
Epiretinal membrane
2.heat map
The system highlights key regions analyzed by the AI through heat map visualizations, enhancing interpretability for clinicians.
Macular degeneration
Macular degeneration
Macular degeneration
Macular degeneration
Glaucoma
Glaucoma
Glaucoma
Glaucoma
3.Report
To enable users to intuitively review examination results, the system provides the analysis results for easy interpretation.
4.Research and Development
2024: Development of DOCTOREYE X-EYE completed
2025: Regulatory and commercialization processes for DOCTOREYE X-EYE are currently underway
Approval from the Ministry of Food and Drug Safety (No. D 26-1)
Characteristic 01
1.EYE to BRAIN
DOCTOREYE X-BRAIN analyzes optical fundus images to identify potential brain diseases and clinically significant neurological findings, thereby supporting clinical decision-making by healthcare professionals.
(It also provides visual insights into the brain using AI 3D modeling.)
*DOCTOREYE X-BRAIN is currently under research and development.
Characteristic 02
2.Accessibility, Cost
A quick fundus scan makes brain condition analysis accessible and cost-effective, with shorter exam time compared to CT or MRI.
Characteristic 03
3.R&D
We are conducting clinical research in collaboration with healthcare professionals in Korea, utilizing fundus images and MRI data.
characteristic 01
1.EYE to BRAIN
DOCTOREYE X-BRAIN analyzes optical fundus images to identify potential brain diseases and clinically significant neurological findings, thereby supporting clinical decision-making by healthcare professionals.
(It also provides visual insights into the brain using AI 3D modeling.)
characteristic 02
2.Accessibility, Cost
A quick fundus scan makes brain condition analysis accessible and cost-effective, with shorter exam time compared to CT or MRI.
characteristic 03
3.R&D
We are conducting clinical research in collaboration with healthcare professionals in Korea, utilizing fundus images and MRI data.
*DOCTOREYE X-BRAIN is currently under research and development.
Characteristic 01
1.On device AI
fundus camera + AIDOCTOR EYE
The AI software DOCTOREYE X-EYE is designed to be integrated into fundus cameras. Following image acquisition, the system can analyze fundus images within seconds to detect the presence of ophthalmic diseases including Diabetic retinopathy, age-related Macular degeneration, Glaucoma, and Epiretinal membrane, thereby supporting clinical decision-making by healthcare professionals.
*On device AI is currently under R&D
Characteristic 02
2.Auto shot
With its automatic imaging capability, RETVIEW100 allows fundus imaging to be easily performed by medical staff without specialized ophthalmic training.
Auto Tracking
Auto Focusing
Auto Shot
characteristic
On device AI
fundus camera + AIDOCTOR EYE
The AI software DOCTOREYE X-EYE is designed to be integrated into fundus cameras. Following image acquisition, the system can analyze fundus images within seconds to detect the presence of ophthalmic diseases including Diabetic retinopathy, age-related Macular degeneration, Glaucoma, and Epiretinal membrane, thereby supporting clinical decision-making by healthcare professionals.
*On device AI is currently under R&D
Achievements
Presented at AAAI 2026 & Selected for IAAI Track 2
AAAI 2026 Piehealthcare
Piehealthcare presented its AI-based retinal diagnosis framework, “REMEDIS,” at AAAI 2026 in Singapore following the confirmation of its publication in an AAAI-affiliated journal (October 2025).
The research was officially selected for IAAI Track 2, where Senior Researcher Jeongwoo Park presented the work, demonstrating advanced capabilities in training-free zero-shot composed image retrieval (CIR).
Minister’s Award of the Ministry of SMEs and Startups (Korea)
Grand Prize (Top Award), 2025 SME Management Innovation Competition
2025 Suwon City Outstanding SME Entrepreneur Award
Grand Prize in the Management Innovation Category
Korea Innovators Community Summit
KOREA Frontier
Piehealthcare was selected as a Korea Frontier company and participated in the 2025 Korea Innovative Startup Summit. In addition, the company plans to engage in the World Economic Forum’s Innovators Communities over the next two years.
Achievements
Presented at AAAI 2026 & Selected for IAAI Track 2
AAAI 2026 Piehealthcare
Piehealthcare presented its AI-based retinal diagnosis framework, “REMEDIS,” at AAAI 2026 in Singapore following the confirmation of its publication in an AAAI-affiliated journal (October 2025).
The research was officially selected for IAAI Track 2, where Senior Researcher Jeongwoo Park presented the work, demonstrating advanced capabilities in training-free zero-shot composed image retrieval (CIR).
Awards
Minister’s Award of the Ministry of SMEs and Startups (Korea)
Grand Prize (Top Award), 2025 SME Management Innovation Competition
2025 Suwon City Outstanding SME Entrepreneur Award
Grand Prize in the Management Innovation Category
Korea Innovators Community Summit
KOREA Frontier
Piehealthcare was selected as a Korea Frontier company and participated in the 2025 Korea Innovative Startup Summit. In addition, the company plans to engage in the World Economic Forum’s Innovators Communities over the next two years.
